Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase IV Study of TRAVATAN 0.004% in Subjects With Iris Pigmentation Changes
This study is ongoing, but not recruiting participants.
Study NCT00047554   Information provided by Alcon Research
First Received: October 8, 2002   Last Updated: June 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Open-Angle Glaucoma
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Glaucoma, Open-Angle
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Travatan 0.004%
Additional drug interventions recognized in this trial
Travoprost
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Alcon Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services